Massachusetts General Hospital Massachussetts General Hospita — Boston, Massachusetts

Massachusetts General Hospital Massachussetts General Hospita is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Massachussetts General Hospita has participated in 1 clinical trials.

Therapeutic areas: Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Massachussetts General Hospita?

Massachusetts General Hospital Massachussetts General Hospita has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Massachussetts General Hospita conducted?

Massachusetts General Hospital Massachussetts General Hospita has 1 clinical trials on record. Their work covers Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM).

Is Massachusetts General Hospital Massachussetts General Hospita accredited by Crixeo Health?

Massachusetts General Hospital Massachussetts General Hospita has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Massachussetts General Hospita?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.